Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Valero

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Journal of Hematology & Oncology|April 1, 2017
Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphomaP Balsas, A Esteve-Arenys, J Roldán, et al.
The FEBS Journal|March 24, 2025
Mammalian TatD DNase domain containing 1 (TATDN1) is a proteostasis-responsive gene with roles in ventricular structure and neuromuscular functionGisel Barés, Aida Beà, Anna Sancho-Balsells, et al.
Blood Advances|September 8, 2020
PI3Kδ inhibition reshapes follicular lymphoma-immune microenvironment cross talk and unleashes the activity of venetoclaxNeus Serrat, Martina Guerrero-Hernández, Alba Matas-Céspedes, et al.
British Journal of Haematology|October 11, 2021
Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphomaIvan Dlouhy, Kennosuke Karube, Anna Enjuanes, et al.
Haematologica|September 29, 2018
Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemiaNeus Giménez, Alejandra Martínez-Trillos, Arnau Montraveta, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Journal of Hematology & Oncology|April 1, 2017
Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphomaP Balsas, A Esteve-Arenys, J Roldán, et al.
The FEBS Journal|March 24, 2025
Mammalian TatD DNase domain containing 1 (TATDN1) is a proteostasis-responsive gene with roles in ventricular structure and neuromuscular functionGisel Barés, Aida Beà, Anna Sancho-Balsells, et al.
Blood Advances|September 8, 2020
PI3Kδ inhibition reshapes follicular lymphoma-immune microenvironment cross talk and unleashes the activity of venetoclaxNeus Serrat, Martina Guerrero-Hernández, Alba Matas-Céspedes, et al.
British Journal of Haematology|October 11, 2021
Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphomaIvan Dlouhy, Kennosuke Karube, Anna Enjuanes, et al.
Haematologica|September 29, 2018
Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemiaNeus Giménez, Alejandra Martínez-Trillos, Arnau Montraveta, et al.
Pageof 6